Verano Holdings (VRNO) Profit After Tax (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Profit After Tax of -$17.8 million for Q1 2026, down 54.78% year-over-year from -$39.4 million in Q1 2025, and up 90.28% quarter-over-quarter from -$183.4 million in Q4 2025.
Verano Holdings (VRNO) Profit After Tax (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Profit After Tax for 6 consecutive years, with -$17.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax fell 54.78% year-over-year to -$17.8 million; the TTM figure through Mar 2026 stood at -$264.2 million (up 24.2% YoY), while the FY2025 annual figure was -$257.9 million, up 24.56% from the prior year.
- Profit After Tax grew to -$17.8 million in Q1 2026 per VRNO's latest filing, from -$183.4 million in the prior quarter.
- Across five years, Profit After Tax topped out at -$214000.0 in Q1 2022 and bottomed at -$272.7 million in Q4 2024.
- Historically, Profit After Tax has averaged -$59.1 million across 5 years, with a median of -$19.2 million in 2025.
- Annual changes were most pronounced in 2022 — Profit After Tax jumped 66.72% — and 2023, when it tumbled 4216.36%.
- Verano Holdings' Profit After Tax stood at -$216.1 million in 2022, then soared by 64.27% to -$77.2 million in 2023, then slumped by 253.21% to -$272.7 million in 2024, then surged by 32.74% to -$183.4 million in 2025, then jumped by 90.28% to -$17.8 million in 2026.
- Business Quant data shows VRNO's Profit After Tax at -$17.8 million in Q1 2026, -$183.4 million in Q4 2025, and -$43.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Verano Holdings | 450.50 Mn | 365.31 Mn | 99.70 Mn | -13.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.41 Mn |
| Mar 31, 2026 | -17.82 Mn |
| Dec 31, 2025 | -183.41 Mn |
| Sep 30, 2025 | -43.83 Mn |
| Jun 30, 2025 | -19.15 Mn |
| Mar 31, 2025 | -11.52 Mn |
| Dec 31, 2024 | -272.71 Mn |
| Sep 30, 2024 | -42.57 Mn |
| Jun 30, 2024 | -21.76 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | -77.21 Mn |
| Sep 30, 2023 | -17.84 Mn |
| Jun 30, 2023 | -13.06 Mn |
| Mar 31, 2023 | -9.24 Mn |
| Dec 31, 2022 | -216.11 Mn |
| Sep 30, 2022 | -42.99 Mn |
| Jun 30, 2022 | -9.85 Mn |
| Mar 31, 2022 | -214,000.00 |
| Dec 31, 2021 | -6.83 Mn |
| Sep 30, 2021 | -12.51 Mn |